Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Titel:
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Auteur:
Grebely, Jason Dalgard, Olav Cunningham, Evan B. Hajarizadeh, Behzad Foster, Graham R. Bruggmann, Philip Conway, Brian Backmund, Markus Robaeys, Geert Swan, Tracy Amin, Janaki Marks, Philippa S. Quiene, Sophie Applegate, Tanya L. Weltman, Martin Shaw, David Dunlop, Adrian Hellard, Margaret Bruneau, Julie Midgard, HÃ¥vard Bourgeois, Stefan Staehelin, Cornelia Dore, Gregory J.